It'S Hanbul Co., Ltd. (KRX:226320)
South Korea · Delayed Price · Currency is KRW 11,320
+20 (0.18%)
At close: Apr 28, 2026
It'S Hanbul Revenue
In the year 2025, It'S Hanbul had annual revenue of 153.39B KRW with 7.69% growth. It'S Hanbul had revenue of 42.03B in the quarter ending December 31, 2025, with 2.69% growth.
Revenue
153.39B
Revenue Growth
+7.69%
P/S Ratio
1.30
Revenue / Employee
1.94B
Employees
79
Market Cap
199.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 153.39B | 10.96B | 7.69% |
| Dec 31, 2024 | 142.43B | 6.98B | 5.15% |
| Dec 31, 2023 | 135.45B | 4.74B | 3.62% |
| Dec 31, 2022 | 130.71B | -9.46B | -6.75% |
| Dec 31, 2021 | 140.18B | -6.20B | -4.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aekyung Industrial | 654.53B |
| Kolmar Holdings | 630.11B |
| KOLMAR BNH | 574.88B |
| VT Co., Ltd. | 437.18B |
| Able C&C | 242.00B |
| Tonymoly | 220.27B |
| Monalisa | 140.89B |
| NeoPharm CO., LTD. | 132.18B |